- PT
- |
- EN
Medical oncologist with a degree and residency in clinical medicine at UFRJ, residency in clinical medicine at Rush-Presbyterian St-Luke’s, fellowship in oncology at Northwestern University, both in Chicago, United States. PhD at the National Cancer Institute, where he works as a doctor and researcher. Coordinator of the oncology service at Clínica São Vicente – Rede D’Or.
Keywords: Cancer Prevention, Surveillance and Control; Breast Cancer with a focus on disparities and access to treatment
EDUCATION
PhD in Oncology from the National Cancer Institute
Residency in Clinical Medicine at the Federal University of Rio de Janeiro
Specialization in Hematology Oncology at Northwestern University, United States
INVESTIGATION AREAS
Oncology
AWARDS AND HONORS
Fellowship in Oncology at Northwestern University, Chicago
Bretas G, Renna NL, Bines J. Practical considerations for expediting breast cancer treatment in Brazil. Lancet Reg Health Am. 2021 Aug 3;2:100028. PMID: 36779036; PMCID: PMC9904000.
doi: 10.1016/j.lana.2021.100028
Bines J, Small IA, Sarmento R, Kestelman F, Silva S, Rodrigues FR, Faroni L, Gonçalves A, Ebecken E, Maroun P, Millen E, Bonamino M. Does the Sequence of Anthracycline and Taxane Matter? The NeoSAMBA Trial. Oncologist. 2020 Sep;25(9):758-764. Epub 2020 Jun 23. PMID: 32476183; PMCID: PMC7485342.
doi: 10.1634/theoncologist.2019-0805
von Minckwitz G, Procter M, de Azambuja E, Zardavas D, Benyunes M, Viale G, Suter T, Arahmani A, Rouchet N, Clark E, Knott A, Lang I, Levy C, Yardley DA, Bines J, Gelber RD, Piccart M, Baselga J; APHINITY Steering Committee and Investigators. Adjuvant Pertuzumab and Trastuzumab in Early HER2-Positive Breast Cancer. N Engl J Med. 2017 Jul 13;377(2):122-131. Epub 2017 Jun 5. Erratum in: N Engl J Med. 2017 Aug 17;377(7):702. Erratum in: N Engl J Med. 2018 Oct 18;379(16):1585. PMID: 28581356; PMCID: PMC5538020.
doi: 10.1056/NEJMoa1703643
Bines J, Earl H, Buzaid AC, Saad ED. Anthracyclines and taxanes in the neo/adjuvant treatment of breast cancer: does the sequence matter? Ann Oncol. 2014 Jun;25(6):1079-85.
doi: 10.1093/annonc/mdu007
Bines J, Dienstmann R, Obadia RM, Branco LGP, Quintella DC, Castro TM, Camacho PG, Soares FA, Costa MEF. Activity of megestrol acetate in postmenopausal women with advanced breast cancer after nonsteroidal aromatase inhibitor failure: a phase II trial. Ann Oncol. 2014 Apr;25(4):831-836.
doi: 10.1093/annonc/mdu015
